CLSI M7 A8 : 8ED 2008

Abstract
Committee Membership
Foreword
Summary of Major Changes in This Document
Summary of CLSI Processes for Establishing Interpretive
Criteria and QC Ranges
CLSI References Methods vs Commercial Methods and CLSI vs
FDA Breakpoints (interpretive criteria)
Subcommittee on Antimicrobial Susceptibility Testing Mission
Statement
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Indications for Performing Susceptibility Tests
6 Selection of Antimicrobial Agents for Routine Testing
   and Reporting
7 Antimicrobial Agents
8 Inoculum Preparation for Dilution Tests
9 Agar Dilution Procedure
10 Broth Dilution Procedures (Macrodilution and Microdilution)
11 Fastidious Organisms
12 Organisms Requiring Special Consideration
13 Inducible Clindamycin Resistance
14 Beta-Lactamase Tests
15 Reporting of MIC Results
16 Quality Control and Quality Assurance Procedures
17 Limitations of Dilution Test Methods
18 Screening Tests
References
Appendix A - Quality Control Protocol Flow Charts
Appendix B - Preparation of Supplements, Media and Reagents
Appendix C - Conditions for Dilution Antimicrobial
             Susceptibility Tests
Appendix D - Quality Control Strains for Antimicrobial
             Susceptibility Tests
Appendix E - Quality Control Strain Maintenance
Summary of Comments and Subcommittee Responses
Summary of Delegate Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI References Materials